Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chau

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
Clinical Colorectal Cancer|January 10, 2016
Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?Elizabeth C Smyth, Noelia Tarazona, Clare Peckitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient dataIan Chau, Andy R Norman, David Cunningham, et al.
Clinical Colorectal Cancer|December 3, 2014
FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experienceSing Yu Moorcraft, Khurum Khan, Clare Peckitt, et al.
The British Journal of Radiology|March 4, 2025
Enhancement of colorectal cancer liver metastases with gadoxetate-enhanced MRI at multiple time points is associated with disease-free survival following hepatectomyJoshua Shur, Leila Kafaei, Angela Riddell, et al.
Critical Reviews in Oncology/Hematology|November 4, 2019
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolutionKhurum Khan, Nicola Valeri, Charles Dearman, et al.
World Journal of Gastrointestinal Oncology|September 5, 2017
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancerMichael Davidson, Ian Chau, David Cunningham, et al.
Trials|January 10, 2016
Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient surveySing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, et al.
Chinese Medicine|November 1, 2023
Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trialsJingya Yang, Yuxiao Li, Chi Ian Chau, et al.
Clinical Colorectal Cancer|August 23, 2011
Nonsurgical management of esophageal adenocarcinomaDorothy M Gujral, Maria A Hawkins, Barbara Grilli Leonulli, et al.
Frontiers in Pharmacology|November 9, 2023
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trialsYuxiao Li, Jingya Yang, Chi Ian Chau, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Clinical Colorectal Cancer|January 10, 2016
Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?Elizabeth C Smyth, Noelia Tarazona, Clare Peckitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient dataIan Chau, Andy R Norman, David Cunningham, et al.
Clinical Colorectal Cancer|December 3, 2014
FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experienceSing Yu Moorcraft, Khurum Khan, Clare Peckitt, et al.
The British Journal of Radiology|March 4, 2025
Enhancement of colorectal cancer liver metastases with gadoxetate-enhanced MRI at multiple time points is associated with disease-free survival following hepatectomyJoshua Shur, Leila Kafaei, Angela Riddell, et al.
Critical Reviews in Oncology/Hematology|November 4, 2019
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolutionKhurum Khan, Nicola Valeri, Charles Dearman, et al.
World Journal of Gastrointestinal Oncology|September 5, 2017
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancerMichael Davidson, Ian Chau, David Cunningham, et al.
Trials|January 10, 2016
Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient surveySing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, et al.
Chinese Medicine|November 1, 2023
Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trialsJingya Yang, Yuxiao Li, Chi Ian Chau, et al.
Clinical Colorectal Cancer|August 23, 2011
Nonsurgical management of esophageal adenocarcinomaDorothy M Gujral, Maria A Hawkins, Barbara Grilli Leonulli, et al.
Frontiers in Pharmacology|November 9, 2023
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trialsYuxiao Li, Jingya Yang, Chi Ian Chau, et al.
Pageof 27